公众号 / 文章技术与安全

投资人工智能与数字健康——放射学创新者需要了解什么

Investing in Artificial Intelligence and Digital Health-What Radiology Innovators Need to Know.
PubMed 文献 · J Am Coll Radiol · 2024-07-03

本文从执业风险合伙人的视角,描述诊断放射学市场中人工智能与数字产品创新获得资金所需的关键考量、标准与框架,以及当前这类创新的融资环境;

要点

  • 放射科医生、研究者、技师和领导者具备开发前沿创新的技能,但实现创新通常需要资金。
  • 文章从执业风险合伙人视角介绍投资决策的关键考量、标准与框架及当前融资环境。

核心结论

  • 诊断放射学市场是创新重镇,人工智能与数字产品是重要推动力;将创新落地通常需要资金,文章从风险合伙人视角说明投资决策的关键考量、标准与框架及当前融资环境。

研究设计与样本

  • 本文为经验文章,从执业风险合伙人的视角描述投资决策的关键考量、标准与框架及当前融资环境,未报告研究设计、样本量或中心数。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Expected to grow at a 5.5% compound annual growth rate and reach a market of $34.6 billion by 2028, the diagnostic radiology market is an innovation powerhouse, in significant part due to artificial intelligence and digital products. Many radiologists, researchers, technologists, and leaders possess the skills to develop cutting-edge innovations to improve patient care. However, invariably funding is needed to bring these innovations to fruition. Here we describe, from the vantage point of a practicing venture partner, the key considerations, criteria, and frameworks used when making decisions of what, when, and who to invest funding in. We also describe the current funding climate for these innovations.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Bok GL. Investing in Artificial Intelligence and Digital Health-What Radiology Innovators Need to Know. J Am Coll Radiol. 2024. PMID: 38969252. doi:10.1016/j.jacr.2024.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。